VA Northern California Health Care System, Sacramento, CA, USA.
Pharmacoepidemiol Drug Saf. 2011 Dec;20(12):1262-8. doi: 10.1002/pds.2129. Epub 2011 Mar 29.
Prescription monitoring programs scrutinize the prescribing of controlled substances to diminish the utilization of multiple prescribers (aka. "doctor shopping"). The use of multiple prescribers is not a problem per se and can be legitimate, as when the patient's regular physician is not available or a concurrent painful condition is being cared for by a different practitioner.
The primary objective of this study was to determine if those patients who used a few prescribers (two to five) in a 1-year period were distinguishable from those who used only one prescriber.
We performed a secondary data analysis of the California Prescription Monitoring Program, the Controlled Substance Utilization Review and Evaluation System, by using data collected during 1999-2007.
The group who used a few providers (two to five) differed substantially from those who visited one provider over a 1-year period. However, the dissimilarity did not suggest that these patients were more prone to the abuse of opioids.
The decision not to investigate patients who visit a low number of multiple prescribers (two to five) appears to be justifiable. If the number of providers in a given period of time is used to determine if a patient should be challenged as being a "doctor shopper," cutoffs with high specificity (low false-positive rates) should be chosen. Further epidemiologic research is needed to determine the association of the number of prescribers and misuse and/or abuse of opioids.
处方监测计划审查管制药物的处方情况,以减少多名处方医生(又名“医生购物”)的使用。多名处方医生的使用本身并不是一个问题,而且可能是合理的,例如当患者的常规医生无法提供服务或同时存在其他疼痛状况需要由不同的医生进行治疗时。
本研究的主要目的是确定在一年内使用少数处方医生(两到五个)的患者是否与仅使用一个处方医生的患者有所区别。
我们对加利福尼亚处方监测计划(受控物质利用审查和评估系统)进行了二次数据分析,使用了 1999 年至 2007 年期间收集的数据。
在一年内使用少数提供者(两到五个)的患者群体与那些仅就诊于一个提供者的患者群体有很大的不同。然而,这种差异并不能表明这些患者更容易滥用阿片类药物。
不调查在一年内就诊于少数多个处方医生(两到五个)的患者的决定似乎是合理的。如果在特定时间段内使用提供者的数量来确定患者是否应被视为“医生购物者”,则应选择具有高特异性(低假阳性率)的截止值。需要进一步进行流行病学研究,以确定提供者数量与阿片类药物的误用和/或滥用之间的关联。